Benitec Biopharma (BNTC)
(Delayed Data from NSDQ)
$8.15 USD
-0.01 (-0.12%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $8.13 -0.02 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Benitec Biopharma Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -19.56 | -18.21 | -13.88 | -8.27 |
Depreciation/Amortization & Depletion | NA | 0.14 | 0.17 | 0.23 | 0.19 |
Net Change from Assets/Liabilities | NA | 0.71 | 1.04 | 0.01 | 0.13 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.70 | 1.11 | 0.81 | 0.42 |
Net Cash From Operating Activities | NA | -18.01 | -15.90 | -12.83 | -7.54 |
Property & Equipment | NA | 0.00 | -0.01 | -0.22 | -0.09 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 0.00 | -0.01 | -0.22 | -0.09 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 17.88 | 0.00 | 25.75 | 2.25 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -1.87 | 0.00 | -3.23 | -0.48 |
Net Cash from Financing Activities | NA | 16.02 | 0.00 | 22.52 | 1.77 |
Effect of Exchange Rate Changes | NA | 0.41 | 0.20 | 0.50 | -0.06 |
Net Change In Cash & Equivalents | NA | -1.59 | -15.71 | 9.97 | -5.92 |
Cash at Beginning of Period | NA | 4.08 | 19.78 | 9.80 | 15.72 |
Cash at End of Period | NA | 2.49 | 4.08 | 19.77 | 9.80 |
Diluted Net EPS | NA | -14.12 | -37.93 | NA | -137.76 |
Fiscal Year End for Benitec Biopharma Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -17.03 | -12.75 | -5.95 | -19.56 |
Depreciation/Amortization & Depletion | NA | 0.06 | 0.04 | 0.02 | 0.14 |
Net Change from Assets/Liabilities | NA | 0.29 | 2.46 | 1.20 | 0.71 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 0.57 | 0.31 | 0.15 | 0.70 |
Net Cash From Operating Activities | NA | -16.11 | -9.94 | -4.58 | -18.01 |
Property & Equipment | NA | -0.18 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.18 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 30.92 | 30.92 | 30.88 | 17.88 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -2.96 | -2.96 | -2.96 | -1.87 |
Net Cash from Financing Activities | NA | 27.96 | 27.96 | 27.92 | 16.02 |
Effect of Exchange Rate Changes | NA | 0.00 | -0.12 | 0.05 | 0.41 |
Net Change In Cash & Equivalents | NA | 11.67 | 17.90 | 23.39 | -1.59 |
Cash at Beginning of Period | NA | 2.49 | 2.49 | 2.49 | 4.08 |
Cash at End of Period | NA | 14.16 | 20.39 | 25.88 | 2.49 |
Diluted Net EPS | NA | -1.64 | -2.64 | -2.76 | 1,590.64 |